The Wegovy weight-loss pill: what you need to know Game-changing oral drug has similar success rate to injections with potentially serious side-effects The upcoming release of the UKs first weight-loss pill, Wegovy, has been described as game-changing by a leading pharmacy provider
The enthusiasm around peptides for nerve repair is justified by the science, but overstating the evidence helps no one
The goal is to keep IGF-1 in an appropriate range, not to maximize it, because IGF-1 is a growth signal and excessive levels raise concerns over time
That typically includes the virtual clinical evaluation, the prescription, and pharmacy fulfillment
Effects on GLP-1 appear to be highly contradictory, with different isolated dietary fibers bumping GLP-1 up, some dropping it down, and others having no effect